David Brown, Sabrient's Chief Market Strategist, discusses the 2012 Baker's Dozen on Bloomberg Radio.

Listen here. Read more about Baker's Dozen Featured on Bloomberg Radio

walter / Tag: 2012, Baker's Dozen, Sabrient, Top Stocks / 0 Comments

Sabrient's 2012 Baker's Dozen has been picked up and recirculated by a number of media outlets including The Wall Street Journal, MarketWatch, MSN Money, and Yahoo! Finance.

Here are the links: Read more about News & Views: 2012 Sabrient Baker's Dozen Media Coverage

walter / Tag: 2012, Baker's Dozen, Sabrient, Top Stocks / 0 Comments

Cancer is a class of diseases in which a group of cells display uncontrolled growth.  Some cancers invade or intrude upon adjacent tissues, then destroy that tissue/organ, and then spread (metastasize) to other locations in the body via lymph or blood.  These three malignant properties of cancers differentiate them from benign tumors, which do not invade or metastasize.  All of these diseases suggest that there will be a need for personalized therapy, as even within a specific type of cancer, there is wide heterogeneity in clinicopathological features.  For instance, leukemia, lymphoma, mye Read more about Another Immune Company Play - Immunomedics

ilene / Tag: biib, imgn, immu, Sabrient / 0 Comments

The Dark Horse Hedge is a new portfolio being built by Scott Brown of Sabient and Ilene at Phil's Stock World.  We started the DHH newsletter on June 30, and have been adding long and short positions over the past two weeks.  Click here to read more about DHH and our thoughts on the market, and to follow along as we add new stocks to our growing portfolio of long and short positions. Read more about THE DARK HORSE HEDGE 7-18-10

ilene / Tag: Dark Horse Hedge, Phil's Stock World, Sabrient, STI, TEX, USG, WDC / 0 Comments
Scott MartindaleSabrient’s fundamentals-based ETF rankings, based on our new and powerful SectorCast model, has proven to be quite predictive for identifying the best (most undervalued) and worst (most overvalued) sectors, with a 1-month forward look. This week, Healthcare continues to lead by a healthy margin.

 

smartindale / Tag: absolute-return, long/short, Sabrient, sector-analysis, SectorCast, sectors, stock-trading / 0 Comments